“Chennai has become a major hub for the CRO industry”

Quest Life Sciences’ managing director Mr TS Jaishankar outlines the company’s presence in Chennai and how the company chose to acquire Fortis Clinical Research


Quest Life Sciences’ managing director Mr TS Jaishankar

Could you give a brief outline of Quest's services?
Quest Life Sciences is a clinical research organization. We specialize in the conduct of Bioequivalence/Bioavailability studies for the generic pharma industry. Besides we conduct Phase II to Phase IV clinical trials on patients in hospitals.

Our major strength is technical support that we provide to the clients from IVIVC guidance to designing the protocol and implementation of the clinical trials. We have conducted nearly 1000 trials so far in a period of last 10 years.

Has the company forayed into countries outside India?
The biggest advantage of clinical trials in India is the vast pool of subjects, disease profiles and ability to induct volunteers or patients in the shortest possible time. This coupled with a scientific pool of highly qualified and experienced pharmaceutical scientist has made India the centre for clinical trials across the world.

In effect every pharmaceutical company in the world has recognized India's capabilities and advantages. So naturally we are gradually expanding our operations all over the world. Currently we have offices or Resident Managers in the US, Moscow and Thailand. Our main target is the regulated market. We now see a huge opportunity even in Rest of the World (RoW) market. Rules are becoming stringent day-by-day. Some countries such as Mexico, Thailand, and Russia have made it mandatory that all the clinical trials and BE studies to be conducted in their respective countries only.

Quest has recently acquired Fortis Clinical Research? What was the reason to choose Fortis and could you elaborate on the financial details of the transaction?
Quest Life Sciences is indeed very happy to have been able to acquire the entire assets of FCRL. FCRL is one of the established CROs in India and having several regulatory approvals such as USFDA, MHRA UK, ANVISA, and EMEA GERMANY, to name a few.


Previous 1 Next
2 Comment Comment 1 - 2 of 2

chennaispeakers 16 November 2015 at 01:18 PM

nice www.chennaispeakers.com



Raja subburayalu 14 November 2015 at 04:25 PM

Being a CRO, you also can have formulation development facility which can strengthen your business and also will help in supporting customers.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email